Skip to main content

ADVERTISEMENT

Dominik Scharnbeck, MD

Original Contribution
03/30/2017
This study compares early device success, procedural success, and 30-day safety endpoint according to the new Mitral Valve Academic Research Consortium criteria (MVARC) in severe primary and secondary mitral regurgitation (MR) patients.
This study compares early device success, procedural success, and 30-day safety endpoint according to the new Mitral Valve Academic Research Consortium criteria (MVARC) in severe primary and secondary mitral regurgitation (MR) patients.
This study compares early device...
03/30/2017
Journal of Invasive Cardiology